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ABSTRACT
Background: In contrast to Staphylococcus aureus-derived superantigenic exotoxins, the role of non-
superantigenic exotoxins in the pathogenesis of eosinophilic airway diseases remains obscure. We sought to
characterize S. aureus alpha-toxin-induced cellular responses in chronic rhinosinusitis with nasal polyps
(CRSwNP).
Methods: Dispersed nasal polyp cells and uncinate tissue cells were prepared from patients with CRS with
and without nasal polyps, respectively. Cells were incubated with various concentrations of alpha-toxin or
staphylococcal enterotoxin B and then the levels of IL-5, IL-13, IFN-γ, IL-17A, and IL-10 in the cell supernatants
were determined. The pathophysiological significance of alpha-toxin-induced cytokine production was also de-
termined including radiological severity of rhinosinusitis, tissue and blood eosinophilia, serum total IgE level,
and 1-s forced expiratory volumeforced vital capacity ratio (FEV1FVC).
Results: Nasal polyp cells produced substantial amounts of IL-5, IL-13, IFN-γ, IL-17A, and IL-10 in response
to alpha-toxin. Cytokine production was higher in nasal polyp cells than in uncinate tissue cells. The potency of
alpha-toxin in stimulating IL-5, IL-13, and IL-10 production was comparable to that of enterotoxin. Alpha-toxin-
induced IFN-γ, IL-17A, and IL-10 production significantly and negatively correlated with the degree of eosino-
phil infiltration into nasal polyps. Conversely, alpha-toxin-induced IFN-γ and IL-10 production significantly and
positively correlated with FEV1FVC. IL-10 production was significantly lower in asthmatic patients compared to
non-asthmatics
Conclusions: S. aureus-derived alpha-toxin can provoke cellular responses in nasal polyps. These re-
sponses, especially failure to synthesize IL-10, may play a role in the pathophysiology of CRSwNP.
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INTRODUCTION
Chronic rhinosinusitis with nasal polyps (CRSwNPs)
is characterized by eosinophilic inflammation, and is
often associated with asthma and aspirin sensitivity.1
While the precise etiology and pathophysiology un-
derlying this disease remains poorly understood, im-
balances in local Th1, Th2, Th17, and Treg responses
appear to be involved.2,3
Components and products derived from microbes
such as viruses, fungi, and bacteria can elicit cellular
responses in patients with CRSwNP.4-7 Staphylococcus
aureus exotoxins are among the best characterized
elicitors of cellular responses and are thought to be
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heavily involved in the pathogenesis of CRSwNP
through their behavior as superantigens.4,8,9
In addition to superantigenic exotoxins, S. aureus
cells also contain other immunogenic components,
such as the capsule, enzymes, and non-superan-
tigenic toxins.10,11 Since S. aureus per se induces an
inflammatory reaction in airway cells, these compo-
nents may also play a role in the pathogenesis of
CRSwNP.12
Alpha-toxin is one of the non-superantigenic exo-
toxins produced by S. aureus.13 Alpha-toxin is a basic
protein consisting of 293 amino acids. Almost all S.
aureus strains possess the gene that encodes alpha-
toxin, hla. Also known as alpha-hemolysin, alpha-
toxin binds to phospholipids on the surface of eryth-
rocytes and then forms a cylindrical heptamer in the
cell membrane, which induces hemolysis.14
Alpha-toxin can regulate immune responses in hu-
mans, including IL-1β release by monocytes, IL-8 se-
cretion by monocytic or epithelial cell lines, LTB4 re-
lease from neutrophils, t-bet expression and IFN-γ
production by CD4+ T cells, and IL-17A and IL-22 pro-
duction by peripheral blood mononuclear cells.13,15-19
The findings that S. aureus frequently colonizes the
human nostril and that colonization by S. aureus is
higher in patients with CRSwNP suggest that S.
aureus alpha-toxin may play a significant role in the
pathogenesis of CRSwNP.20,21
In the present study, we sought to determine the
effect of S. aureus alpha-toxin on cytokine production
using an ex vivo model of CRSwNP.3 In addition, we
investigated the pathophysiological significance of
alpha-toxin-induced cytokine production in CRSwNP
patients.
METHODS
PATIENTS
The study involved 22 Japanese CRSwNP patients
(age range 26-71 years; mean age 57.8 years). The
presence of CRSwNP was determined based upon di-
agnostic criteria reported in a European position pa-
per on rhinosinusitis and nasal polyps.22 All patients
received a low-dose oral administration of 14-
membered ring macrolides including roxithromycin
and clarithromycin for at least 3 months as a basic
medical therapy. Treatment failure was determined
by computed tomography showing persistent abnor-
mal shadows in sinuses. Then they received endo-
scopic sinus surgery. Ten patients were asthmatic,
and one patient was thought to have aspirin exacer-
bated respiratory disease (AERD) based on a history
of asthma attacks precipitated by non-steroidal anti-
inflammatory drugs. For at least eight weeks prior to
surgery none of the participants received systemic
glucocorticoids, and for at least three weeks prior to
surgery none of the participants received pharmaco-
therapy for rhinosinusitis, such as macrolide antibiot-
ics or intranasal glucocorticoids. Prior to surgery,
each patient’s serum total IgE level (Pharmacia,
Uppsala, Sweden), blood eosinophil count, and 1-s
forced expiratory volumeforced vital capacity ratio
(FEV1FVC) were determined. For ethical reason, all
the asthmatic patients received inhaled corticoster-
oids throughout the study period including the time
when the pulmonary function test was performed. A
radiological assessment of the severity of rhinosinusi-
tis in each patient was also performed using the
Lund-Mackay system.22 Sections from surgically ex-
cised nasal polyps were stained with hematoxylineo-
sin solution, and the average number of eosinophils
per high power field (10 × 40) was then determined.5
Nine patients (age range 32-73 years; mean age 54.0
years) with CRS without nasal polyps (CRSsNP) were
enrolled as controls.22 Informed consent for participa-
tion in the study was obtained from each patient, and
the study was approved by the Human Research
Committee of the Okayama University Graduate
School of Medicine, Dentistry and Pharmaceutical
Sciences.
CULTURE OF DISPERSED NASAL POLYP
CELLS AND UNCINATE TISSUE CELLS
Nasal polyps and uncinate tissues were sampled from
patients with CRSwNP and CRSsNP, respectively.
Dispersed nasal polyp cells (DNPCs) and dispersed
uncinate tissue cells (DUTCs) were prepared from
nasal polyps and uncinate tissues, respectively, by en-
zymatic digestion, as previously described.5 1 × 106
DNPCs or DUTCs per mL was stimulated with 0.01,
0.1, or 1.0 ngmL of alpha-toxin (Sigma, St. Louis,
MO, USA) and incubated at 37℃ in a 5% CO2 atmos-
phere. An aliquot of the culture supernatant was col-
lected after 24 and 72 hours and stored at -80℃ for
subsequent cytokine analysis. Alternatively, cells
were stimulated with 1.0 ngmL of staphylococcal en-
terotoxin B (SEB; Toxin Technology, Sarasota, FL,
USA).
CYTOKINE MEASUREMENT
The levels of IL-5, IL-13, IFN-γ, and IL-10 were deter-
mined using Opt EIA sets (BD Biosciences, San Jose,
CA, USA), according to the manufacturer’s instruc-
tions. The level of IL-17A was determined using a Du-
oSet ELISA Development Kit (R&D Systems, Min-
neapolis, MN, USA). The detection limit was 4 pg
mL for IL-5, 2 pgmL for IL-13, 4 pgmL for IFN-γ, 8
pgmL for IL-17A, and 4 pgmL for IL-10.
STATISTICAL ANALYSIS
Values are given as the median. The nonparametric
Mann-Whitney U test was used to compare data be-
tween groups, and Wilcoxon’s signed rank test was
used to analyze data within each group. Correlation
analyses were performed using the Spearman rank
correlation. P-values less than 0.05 were considered
statistically significant. Statistical analyses were per-
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formed with SPSS software (version 11.0, Chicago,
IL, USA).
RESULTS
ALPHA-TOXIN-INDUCED CYTOKINE PRODUC-
TION BY DNPCs
24 h-stimulation of DNPCs with 1 ngmL of alpha-
toxin induced significant increases in the production
of IL-5 (P = 0.005), IL-13 (P = 0.003), IFN-γ (P =
0.003), IL-17A (P = 0.021), and IL-10 (P < 0.001) com-
pared to unstimulated DNPCs. Stimulation with 0.01
ngmL of alpha-toxin did not induce production of
any of the cytokines examined, while stimulation with
0.1 ngmL did induce significant production of IL-10
(P = 0.003). In addition, 72 h-stimulation of DNPCs
with 0.01 ngmL alpha-toxin resulted in a significant
production of all the cytokines tested, and these pro-
ductions were substantially increased in a dose-
dependent manner (Fig. 1; P < 0.001).
COMPARISON OF ALPHA-TOXIN-INDUCED CY-
TOKINE PRODUCTION BY NASAL POLYP
CELLS AND UNCINATE TISSUE CELLS
Stimulation of 1 × 106mL of uncinate tissue cells de-
rived from CRSsNP patients with 1 ngmL of alpha-
toxin for 72 h induced a modest but significant in-
crease in production of IL-5 (P = 0.043), IL-13 (P =
0.006), IFN-γ (P = 0.012), IL-17A (P = 0.012), and IL-
10 (P = 0.018). However, as shown in Figure 2, stimu-
lating the same number of nasal polyp cells derived
from CRSwNP patients in the same manner induced
production of significantly higher levels of these cy-
tokines (IL-5: P = 0.001, IL-13: P = 0.017, IFN-γ: P =
0.006, IL-17A: P = 0.004, IL-10: P = 0.001).
COMPARISON OF CYTOKINE PRODUCTION
FOLLOWING STIMULATION WITH ALPHA-TOXIN
OR SEB
Next, we compared the potency of alpha-toxin and
SEB, with respect to inducing cytokine production by
DNPCs. Stimulation with alpha-toxin induced produc-
tion of a similar amount of IL-5 (P = 0.230), IL-13 (P =
0.516), and IL-10 (P = 0.263) as did stimulation with
SEB (Fig. 3A, B, E). In contrast, production of IFN-γ
(P = 0.002) and IL-17A (P < 0.001) was significantly
lower in DNPCs stimulated with alpha-toxin than in
DNPCs stimulated with SEB (Fig. 3C, D).
PATHOPHYSIOLOGICAL SIGNIFICANCE OF
ALPHA-TOXIN-INDUCED CYTOKINE PRODUC-
TION IN CRSwNP
As shown in Table 1, the production of IL-5 (ρ =
0.146, P = 0.503) and IL-13 (ρ = 0.108, P = 0.621) fol-
lowing a 72-h stimulation with 1 ngmL of alpha-toxin
did not correlate with eosinophil infiltration into nasal
polyps. However, there was a significant negative cor-
relation between local eosinophilia and production of
IFN-γ (ρ = -0.432, P = 0.048), IL-17A (ρ = -0.566, P =
0.009), and IL-10 (ρ = -0.567, P = 0.009) (Fig. 4).
Alpha-toxin-induced cytokine production did not cor-
relate with other pathophysiological parameters, in-
cluding radiological severity of rhinosinusitis, blood
eosinophil count, or serum total IgE or FEV1FVC,
except for positive correlations between IFN-γ pro-
duction and FEV1FVC (ρ = 0.456, P = 0.037) and be-
tween IL-10 production and FEV1FVC (ρ = 0.538, P =
0.014). Production of IL-10 was significantly lower in
asthmatic patients compared to non-asthmatics (P =
0.035); however, the presence of asthma did not af-
fect the production of other cytokines (Fig. 5).
DISCUSSION
In the present study, we characterized the alpha-
toxin-induced cytokine productions from patients
with CRSwNP and CRSsNP. Our results suggest that
antigens other than SEB, namely alpha-toxin in this
study, are also likely targets for stimulatory mole-
cules. Both the innate and the adaptive immune sys-
tems clearly respond to bacterial structural compo-
nents as well as their secreted exotoxins.4 In this
case, alpha-toxin can stimulate a robust synthesis of
cytokines known to be associated with eosinophilic
airway inflammation.
In response to alpha-toxin stimulation, DNPCs pro-
duce substantial amounts of IL-5, IL-13, IFN-γ, IL-17A,
and IL-10, cytokines known to regulate the patho-
genesis of CRSwNP.2,3 In nasal polyps, a majority of
the IL-5-producing cells is T cells, and mast cells and
eosinophils can express IL-5.23 Mononuclear cells
and eosinophils in nasal polyps express IL-13.24,25 We
have previously reported that macrophages, CD4+ T
cells and eosinophils express IL-17A in nasal polyps.3
T cells are the principal source of allergen-induced
IL-10 production in nasal polyps.26 Thus, alpha-toxin
may stimulate these inflammatory cells directly and
or indirectly to produce cytokines. Additional experi-
ments, e.g. whether adherent cell or non-adherent
cell produce cytokines in response to alpha-toxin,
should be performed in order to identify which cells
are the main sources for cytokine production.
High concentrations of alpha-toxin induce cell
death due to the formation of hexameric transmem-
brane pores.13 For example, about two-thirds of Jur-
kat T cells treated with 100 ngmL of alpha-toxin will
undergo subsequent apoptosis.27 In contrast, expo-
sure to lower concentrations of alpha-toxin can in-
duce pro-inflammatory effects in a variety of cells
without causing cell lysis, presumably via alteration
of the cellular ion balance following pore formation,
particularly through calcium influx.16 For example,
exposure of human CD4+ T cells to alpha-toxin at con-
centrations less than 100 ngmL does not lead to cell
death.16 Alpha-toxin concentrations less than 1,000
ngmL were found to be sublytic to human macro-
phages.19 In the present study, we exposed DNPCs
and DUTCs to alpha-toxin at concentrations of 0.01,
Okano M et al.
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Fig.　1　Effect of alpha-toxin of S. aureus on IL-5 (A), IL-13 (B), IFN-γ (C), IL-17A (D) and IL-10 (E) produc-
tion by DNPCs (n = 22). DNPCs were stimulated with 0.01, 0.1, or 1.0 ng/mL of alpha-toxin and incubated 
for either 24 or 72 hours. The rectangle includes the range from the 25th to the 75th percentiles, the hori-
zontal line indicates the median, and the vertical line indicates the range from the 10th to the 90th percen-
tiles. P values were determined by Wilcoxon’s signed-ranks test.
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0.1, and 1.0 ngmL, concentrations which were lower
than those used in previous studies.15-19 Our prelimi-
nary study revealed that 1 ngmL of alpha-toxin does
not induce a substantial number of cells to undergo
cell death, as determined by trypan blue dye exclu-
sion tests (data not shown). These results suggest
that in CRSwNP alpha-toxin induces active produc-
tion of cytokines rather than their release due to cell
lysis.
It seems to be difficult to determine the actual con-
centration of alpha-toxin in the nose because viable S.
aureus may consistently produce the toxin. In addi-
tion, kits to determine the concentration is not com-
mercially available at present. Since hemolysis of
erythrocytes is not generally detected in nasal polyps,
we think that the concentration of alpha-toxin in the
Alpha-Toxin and CRSwNP
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Fig.　2　Comparison of alpha-toxin-induced IL-5 (A), IL-13 (B), IFN-γ (C), IL-17A (D) and IL-10 (E) 
production between DNPCs from patients with CRSwNP (n = 22) and DUTCs from patients with 
CRSsNP (n = 9). The rectangle includes the range from the 25th to the 75th percentiles, the hori-
zontal line indicates the median, and the vertical line indicates the range from the 10th to the 90th 
percentiles. P values were determined by Mann-Whitney’s U test.
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mucus adjacent to the polyps is below 200 nM.14 1
ngml (approximately 30 pM) of alpha-toxin could in-
duce cytokine production including IL-5, IL-13, IFN-γ
and IL-17A by nasal polyp cells, suggesting that
alpha-toxin is being produced in sufficient concentra-
tions that would produce a pro-inflammatory effect in
the polyp tissue.
In response to alpha-toxin stimulation, nasal polyps
cells from CRSwNP produced significantly higher
amounts of IL-5, IL-13, IFN-γ, IL-17A, and IL-10 than
did uncinate tissue cells from CRSsNP. This result
was similar to the previous report by Patou et al., who
demonstrated that SEB stimulated significantly
higher production of IL-2, IL-4, IL-5, IL-10, IL-13, and
IFN-γ in nasal polyps than in inferior turbinates.4 Our
results suggest that, as is the case with SEB, alpha-
toxin induces enhanced immune responses that are
associated with nasal polyp formation in CRSwNP.
Okano M et al.
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Fig.　3　Comparison of IL-5 (A), IL-13 (B), IFN-γ (C), IL-17A (D) and IL-10 (E) production by 
DNPCs between alpha-toxin and SEB stimulation. DNPCs (n = 22) were stimulated with 1.0 ng/
mL of either alpha-toxin or SEB, and incubated for 72 hours. Bar indicates the median. The rect-
angle includes the range from the 25th to the 75th percentiles, the horizontal line indicates the 
median, and the vertical line indicates the range from the 10th to the 90th percentiles. P values 
were determined by Wilcoxon’s signed-ranks test.
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The introduction of a healthy control cohort would
bring more clarity into the project, and our prelimi-
nary results showed that the dispersed cells from
non-inflamed concha bullosa (n = 3) produced less
amounts of IL-5 (73.3 pgml), IL-13 (160.3 pgml),
IFN-γ (766.7 pgml), IL-17A (84.3 pgml), and IL-10
(147.7 pgml) as compared with DNPCs. Although
substantial cases of nasal polyps are grown from unti-
nate tissue, future examination about the comparison
of alpha-toxin-induced cytokine production between
uncinate tissue cells and nasal polyp cells in identical
patients with CRSwNP or AERD will provide valuable
information for understanding the pathogenesis of
this disease such as the mechanisms of nasal polyp
formation.
We previously reported that exposure to SEB at a
concentration of 1 ngmL induces IL-5, IL-13, IFN-γ,
and IL-17A production in DNPCs.3,28 In the present
Alpha-Toxin and CRSwNP
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Table　1　Correlation between pathophysiological characterizations and alpha-toxin-induced cytokine production by DNPCs
Nasal polyp eosinophilia 
(cells/fi eld)
Radiological severity 
(score)
Blood eosinophilia 
(cells/μl)
Serum total IgE 
(IU/ml) FEV1/FVC
IL-5 ρ 0.146 0.103 0.411 -0.089 0.041
P 0.503 0.646 0.060 0.685 0.850
IL-13 ρ 0.108 0.111 0.278 -0.307 0.074
P 0.621 0.620 0.202 0.160 0.735
IFN-γ ρ -0.432 -0.097 -0.263 -0.408 0.456
P 0.048 0.644 0.229 0.061 0.037
IL-17A ρ -0.566 -0.014 -0.372 -0.192 0.298
P 0.009 0.937 0.088 0.377 0.172
IL-10 ρ -0.567 -0.334 -0.295 -0.250 0.538
P 0.009 0.121 0.176 0.252 0.014
ρ and P values were determined by Spearman’s rank correlation coefficient.
study, we also demonstrated that exposing DNPCs to
SEB induces IL-10 production. This result was in
agreement with the previous report by Patou et al.,
which showed that 500 ngmL of SEB induces IL-10
production in nasal polyp explants.3 We found that at
1 ngmL, both alpha-toxin and SEB induce produc-
tion of similar amounts of IL-5, IL-13, and IL-10 in
DNPCs. Our preliminary experiment showed that si-
multaneous exposure to alpha-toxin and SEB did not
display a synergistic effect on cytokine production by
DNPCs as compared with the single exposure. Since
the molecular weight of SEB (approximately 27 kDa)
is similar to that of alpha-toxin (28-30 kDa), these re-
sults suggest that both the superantigenic and non-
superantigenic exotoxins of S. aureus equally induce
Th2 and regulatory immune responses in
CRSwNP.14,29 However, we found that production of
IFN-γ and IL-17A is significantly lower in DNPCs ex-
posed to alpha-toxin than in cells exposed to SEB.
Other studies have shown that IFN-γ and IL-17A play
roles in the pathogenesis of CRS.3,30 For example,
IFN-γ is abundantly expressed in CRSsNP as com-
pared with CRSwNP.30 These results suggest that
SEB affects cytokine production more broadly than
does alpha-toxin, probable due to its superantigenic
profile.
There was a significant negative correlation be-
tween the degree of eosinophil infiltration into nasal
polyps and alpha-toxin-induced production of IFN-γ,
IL-17A, and IL-10 by DNPCs. Studies involving mice
have shown that IFN-γ inhibits airway eosinophilia by
blocking Th2 cell cytokine production, CD4+ T cell
recruitment into airways, andor by suppressing the
function of antigen-presenting cells.31,32 In humans,
80% of mild asthmatics that received IFN-γ via inhala-
tion exhibited a reduction in the number of airway
eosinophils.33 IFN-γ causes an opening of tight junc-
tions in CRS which may lead to shedding and drain-
age of inflammation.34 The present results consist
with the reports, and suggest that IFN-γ has a regula-
tory effect on eosinophilic inflammation in
CRSwNP.34 In contrast, alpha-toxin-induced produc-
tion of IL-5 and IL-13 did not correlate with local
eosinophilia. This result was similar to those of our
previous report, which found no correlation between
SEB-induced production of IL-5 and IL-13 and local
eosinophilia.5 However, as shown in Table 1, the lev-
els of IL-5 production showed a tendency to positively
correlate with blood eosinophilia (ρ = 0.411, P =
0.060). IL-5 is involved in the differentiation and matu-
ration of eosinophils in the bone marrow, migration
to tissue sites, and prevention of eosinophil apopto-
sis.35 Our results suggest that alpha-toxin-induced IL-
5 production is involved in the pathophysiology of
CRSwNP by increasing blood eosinophils. In fact, a
recent study showed that IFN-γ suppresses airway
eosinophilia independent of Th2 cell activation.32
It is known that IL-10 plays a critical role in control-
ling eosinophilic airway inflammation.36 In CRS pa-
tients, IL-10 suppresses IL-6 and TNF-α production
by upper airway dendritic cells.37 Additionally, IL-10
suppresses allergen-induced IL-5 and IFN-γ produc-
tion by DNPCs.32 In the present study, the negative
correlation between the degree of eosinophil infiltra-
tion into nasal polyps and alpha-toxin-induced cy-
tokine production was strongest for IL-10. These re-
sults suggest that alpha-toxin-induced IL-10 produc-
tion plays an important role in protecting eosinophilic
inflammation in CRSwNP.
It remains unclear why IL-10 production is sup-
pressed in DNPCs derived from asthmatic patients.
However, a recent meta-analysis demonstrated the
association between IL-10 promoter gene polymor-
phism and susceptibility to asthma.38 Another study
showed a lower serum concentration of IL-10 in pa-
tients with early-onset current asthma.39 Thus asth-
matic patients may genetically show the impairment
in IL-10 production even in the upper airway.
Alpha-toxin-induced IL-10 production was posi-
tively correlated with FEV1FVC. This may be due to
the inhibitory effect of IL-10 on eosinophilic inflam-
mation by suppression of IL-5 and GM-SCF through
Okano M et al.
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Fig.　4　Relationship between the number of eosinophils in nasal polyps and alpha-toxin-induced 
IL-5 (A), IL-13 (B), IFN-γ (C), IL-17A (D) and IL-10 (E) production by DNPCs (n = 22).
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upregulation of suppressor of cytokine signaling
(SOCS)-3.40 Alternatively, suppression of airway nitric
oxide production by IL-10 may be involved the func-
tion.40
AERD is one of endotypes in CRSwNP.41 Amount
of alpha-toxin (1 ngml)-induced IL-5 (883 pgml), IL-
13 (849 pgml), IFN-γ (2,951 pgml), IL-17A (627 pg
ml) and IL-10 (200 pgml) by DNPC from a patient
with AERD was not an outlier of the average +- stan-
dard deviation of IL-5 (752 +- 640 pgml), IL-13 (670
+- 615 pgml), IFN-γ (5,249 +- 4,583 pgml), IL-17A
(1,305 +- 1,312 pgml) and IL-10 (905 +- 871) of 22
DNPCs, respectively, as determined by Grubbs test
(P > 0.05). This suggests that the data from a patient
with AERD had little effect on skewing the results.
In conclusion, not only superantigenic but also
non-superantigenic exotoxins derived from S. aureus
modulate local immune reactions and affect the
Alpha-Toxin and CRSwNP
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Fig.　5　Comparison of alpha-toxin-induced IL-5 (A), IL-13 (B), IFN-γ (C), IL-17A (D) and IL-10 (E) pro-
duction by DNPCs between non-asthmatic (n = 11) and asthmatic (n = 10) patients. The rectangle in-
cludes the range from the 25th to the 75th percentiles, the horizontal line indicates the median, and the 
vertical line indicates the range from the 10th to the 90th percentiles. P values were determined by Mann-
Whitney’s U test.
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pathophysiology of CRSwNP. It is known that the en-
doscopic sinus surgery can improve pulmonary func-
tion in asthmatic patients.42,43 In addition, Proimos et
al. showed a clear improvement in the use of bron-
chodilators, oral steroids, and need for hospitalization
for asthma after the surgery in asthmatic CRS pa-
tients.44 The present findings may provide new in-
sight into the role of alpha-toxin in the pathogenesis
of eosinophilic airway diseases, including allergic
rhinitis and bronchial asthma, and provide a basis for
the development of novel therapeutic approaches that
target S. aureus in order to limit eosinophilic airway
inflammation.
Okano M et al.
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